|
Anodyne Therapy We
are eager to inform you that our outpatient clinic “Beyond Physical
Therapy” now uses If you have patients with loss of protective sensation (LOPS) due to Diabetic Peripheral Neuropathy and gait and balance abnormalities with a tendency to fall, our Peripheral Neuropathy Treatment Program can help. Excellent clinical outcomes have been demonstrated with Diabetic Peripheral
Neuropathy (DPN) including restoration of protective sensation,
reduction or elimination of neuropathic and ischemic pain and
resolution of chronic non-healing wounds. So far that treatment was only provided in Blount and Morgan County and patients from Knoxville had to travel over 30 miles for that kind of treatment. Currently Anodyne Therapy System will be utilized in our Clinic in convenient location at corner of Middlebrook Pike and Cedar Bluff Rd. by the therapist who initiated this program in Blount County in 2002. We are proud to be one
of very few authorized Anodyne care
centers in the
Knoxville
area. The
Anodyne®
Therapy System uses monochromatic infrared energy (MIRE) to increase
local circulation and reduce pain by disassociating nitric oxide
(NO) from hemoglobin. Nitric
oxide Medicare
recently issued a National Coverage Decision Memorandum[3] that
acknowledges LOPS (loss of protective sensation as measured by a
5.07 Semmes Weinstein Monofilament) as Anodyne®
is non-invasive, drug-free and safe. Best clinical results are
obtained from a minimum of three treatments per week over four weeks
in combination with gait and balance training followed by a home
maintenance program.
Anodyne®
has been used on thousands of patients for more than 7 years with
consistent success in treating non-healing wounds, pain and LOPS [4] [5].
There are no known adverse events or drug interactions when used in
accordance with manufacturer’s recommendations. The only contraindications
are pregnancy and active malignancies. More information is available
at http://www.anodynetherapy.com/. [1] New England Journal of
Medicine, Moncada and Higgs, Volume 329(27), Dec 30, 1993, pp.
2002-2012. [2] Diabetes, Veves et
al., Mar 1998, 47(3): 457-63. [3] National Coverage Decision –
Diabetic Peripheral Neuropathy with Loss of Protective Sensation –
File: CAG-00059, Oct. 17, 2001. [4] Advances in Wound Care,
Horowitz et al., Jan/Feb 1999, 12:35-40. [5] American Diabetes Association
61st Scientific Session, June 22-26, 2001, Abstract #:
1798-PO, Burke et al. |